Spago Nanomedical

Spago Nanomedical

Sweden - Lund
Biotechnology
WebsiteLinkedInCareers Page

Focus: Tumor selective MRI agent; radionuclide cancer treatment

Spago Nanomedical is a life sciences company focused on Tumor selective MRI agent; radionuclide cancer treatment.

Oncology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT04080024A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer
Phase 1
[177Lu]Lu-SN201
Solid Tumor
Phase 1/2
Clinical Trials (1)
NCT06184035A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer
Phase 1/2
Phase 2
Clinical Trials (1)
NCT05664828Efficacy of SN132D in Patients With Suspected Endometriosis
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 3 clinical trials